Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment-Reference-Cited by-同舟云学术

Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment

Published:2001-02-01 Issue:2 Volume:16 Page:403-406
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Odum Jonathan,D'Costa Dominic,Freeth Mark,Taylor David,Smith Neil,MacWhannell Alan

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/16/2/403/23369925/160403.pdf

Reference8 articles.

1. Yap PL, Williams PE. The safety of IVIG preparations. In: Yap PL, ed. Clinical Implications of Intravenous Immunoglobulin Therapy. Churchill Livingstone. 43–62

2. Schifferli JA. Adverse effects of intravenous immunoglobulin. Transfus Sci1992; 13: 331–338

3. Cayco AV, Perazella MA, Hayslett JP. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. J Am Soc Nephrol1997; 8: 1788–1794

4. Stahl S, Schifferli JA. The renal risks of high‐dose intravenous immunoglobulin treatment. Nephrol Dial Transplant1998; 13: 2182–2185

5. Howse M, Bindoff I, Carmichael A. Facial vasculitic rash associated with intravenous immunoglobulin. BMJ1998; 317: 1291

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee;Muscle & Nerve;2023-07-11

2. Multiorgan Failure From Cryoglobulinemic Vasculitis Following Intravenous Immunoglobulin Replacement Therapy;JCR: Journal of Clinical Rheumatology;2016-12

4. Indications and safety of intravenous and subcutaneous immunoglobulin therapy;Expert Review of Clinical Immunology;2011-05

5. Reply;Arthritis & Rheumatism;2010-07-26